Related Experiment Video
Updated: Aug 23, 2026

04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy
Mauri Kouri1, Leena Kankaanranta, Tiina Seppälä
1Department of Laboratory Diagnostics, Helsinki University Central Hospital, P.O. Box 180, FIN-00029 HUCH, Finland.
Abstract:
A large, rapidly progressing, unresectable undifferentiated sinonasal head and neck carcinoma regressed rapidly following single fraction boron neutron capture therapy (BNCT). The main toxicity consisted of mucositis lasting for a few days. The quality of life improved and was excellent until tumour recurrence 6 months after the date of BNCT.